- 专利标题： Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
-
申请号： US14748634申请日： 2015-06-24
-
公开(公告)号： US20150290318A1公开(公告)日： 2015-10-15
- 发明人: Craig J. Eagle , H. Craig Dees , Eric A. Wachter , Jamie Singer
- 申请人： Provectus Pharmaceuticals, Inc. , Pfizer, Inc.
- 申请人地址： US TN Knoxville US NY New York
- 专利权人： Provectus Pharmaceuticals, Inc.,Pfizer, Inc.
- 当前专利权人： Provectus Pharmaceuticals, Inc.,Pfizer, Inc.
- 当前专利权人地址： US TN Knoxville US NY New York
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K31/352
摘要：
A method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic immunomodulatory anticancer agent. A further method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic targeted anticancer agent. The present invention is further directed to pharmaceutical compositions for treatment of cancer. The intralesional chemoablative pharmaceutical composition can comprise an IL chemoablative agent comprising primarily a halogenated xanthene.
公开/授权文献
信息查询
